OBJECTIVES: Standard metrics for evaluating rapid response systems (RRSs) include cardiac and respiratory arrest rates. These events are rare in children; therefore, years of data are needed to evaluate the impact of RRSs with sufficient statistical power. We aimed to develop a valid, pragmatic measure for evaluating and optimizing RRSs over shorter periods of time. METHODS: We reviewed 724 medical emergency team and 56 code-blue team activations in a children's hospital between February 2010 and February 2011. We defined events resulting in ICU transfer and noninvasive ventilation, intubation, or vasopressor infusion within 12 hours as "critical deterioration." By using in-hospital mortality as the gold standard, we evaluated the test characteristics and validity of this proximate outcome metric compared with a national benchmark for cardiac and respiratory arrest rates, the Child Health Corporation of America Codes Outside the ICU Whole System Measure. RESULTS: Critical deterioration (1.52 per 1000 non-ICU patient-days) was more than eightfold more common than the Child Health Corporation of America measure of cardiac and respiratory arrests (0.18 per 1000 non-ICU patient-days) and was associated with >13-fold increased risk of in-hospital death. The critical deterioration metric demonstrated both criterion and construct validity. CONCLUSIONS: The critical deterioration rate is a valid, pragmatic proximate outcome associated with in-hospital mortality. It has great potential for complementing existing patient safety measures for evaluating RRS performance.
OBJECTIVES: Standard metrics for evaluating rapid response systems (RRSs) include cardiac and respiratory arrest rates. These events are rare in children; therefore, years of data are needed to evaluate the impact of RRSs with sufficient statistical power. We aimed to develop a valid, pragmatic measure for evaluating and optimizing RRSs over shorter periods of time. METHODS: We reviewed 724 medical emergency team and 56 code-blue team activations in a children's hospital between February 2010 and February 2011. We defined events resulting in ICU transfer and noninvasive ventilation, intubation, or vasopressor infusion within 12 hours as "critical deterioration." By using in-hospital mortality as the gold standard, we evaluated the test characteristics and validity of this proximate outcome metric compared with a national benchmark for cardiac and respiratory arrest rates, the Child Health Corporation of America Codes Outside the ICU Whole System Measure. RESULTS: Critical deterioration (1.52 per 1000 non-ICU patient-days) was more than eightfold more common than the Child Health Corporation of America measure of cardiac and respiratory arrests (0.18 per 1000 non-ICU patient-days) and was associated with >13-fold increased risk of in-hospital death. The critical deterioration metric demonstrated both criterion and construct validity. CONCLUSIONS: The critical deterioration rate is a valid, pragmatic proximate outcome associated with in-hospital mortality. It has great potential for complementing existing patient safety measures for evaluating RRS performance.
Authors: James M Hoffman; Nicholas J Keeling; Christopher B Forrest; Heather L Tubbs-Cooley; Erin Moore; Emily Oehler; Stephanie Wilson; Elisabeth Schainker; Kathleen E Walsh Journal: Pediatrics Date: 2019-02 Impact factor: 7.124
Authors: Patrick W Brady; Stephen Muething; Uma Kotagal; Marshall Ashby; Regan Gallagher; Dawn Hall; Marty Goodfriend; Christine White; Tracey M Bracke; Victoria DeCastro; Maria Geiser; Jodi Simon; Karen M Tucker; Jason Olivea; Patrick H Conway; Derek S Wheeler Journal: Pediatrics Date: 2012-12-10 Impact factor: 7.124
Authors: Christopher S Parshuram; Karen Dryden-Palmer; Catherine Farrell; Ronald Gottesman; Martin Gray; James S Hutchison; Mark Helfaer; Elizabeth A Hunt; Ari R Joffe; Jacques Lacroix; Michael Alice Moga; Vinay Nadkarni; Nelly Ninis; Patricia C Parkin; David Wensley; Andrew R Willan; George A Tomlinson Journal: JAMA Date: 2018-03-13 Impact factor: 56.272
Authors: Ryan W Morgan; Matthew P Kirschen; Todd J Kilbaugh; Robert M Sutton; Alexis A Topjian Journal: JAMA Pediatr Date: 2021-03-01 Impact factor: 16.193